Masae Ikeda

No ORCID on file · 4 papers in corpus · active 2015-2025

Study types

  • article 4

Condition tags

  • endometrioma 3
  • endometriosis 2
article 2025
Clinical usefulness of E4-phytohemagglutinin reactive C4-binding protein relative front value in serum for distinguishing between ovarian clear cell adenocarcinoma and endometrioma
Clinica chimica acta; international journal of clinical chemistry ·doi:10.1016/j.cca.2025.120219

BACKGROUND AND AIMS: We identified a fully sialylated glycopeptide of the α-chain of Complement 4 binding protein (C4BP) in blood using Liquid chromatography/Mass spectrometry, which helps differentiate ovarian clear cell carcinoma (OCCC) f…

article 2017
Alpha-chain of Complement 4-Binding Protein with Fully-Sialylated Glycans (FS-C4BP): Diagnostic utility for early stage ovarian clear cell carcinoma and endometrioma
article 2016
IS-MW-1-3 A novel biomarker that distinguishes early stage ovarian clear cell adenocarcinomas from benign endometriomas(Group 1 Ovarian Cancer,International Session Mini Workshop)
article 2015
Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma
Gynecologic oncology ·doi:10.1016/j.ygyno.2015.10.012

OBJECTIVE: While a certain fraction of endometriomas can develop de novo epithelial ovarian cancer (EOC) such as clear cell carcinoma (OCCC), there is currently no useful biomarker available for early detection of OCCC from endometriomas. T…